About 10% of breast cancers are due to mutations in genes called BRCA1 and BRCA2. Still, it is not yet fully known the molecular mechanism that explains how the alteration of these genes greatly increases the risk of cancer. An international team led by the researcher of the IDIBELL and the Catalan Institute of Oncology […]
Described a new molecular mechanism altered in breast cancer development Read More »
The gastroenterologist of the University Hospital of Rangueil, Touluse, and researcher at INSERM, Louis Buscail explained his latest advances in gene therapy for advanced pancreatic cancer in IDIBELL seminar series on 11 November. Currently, the only effective treatment for pancreatic cancer is surgery. The chemotherapeutic agent gemcitabine improves the survival of the patient but survival
Five IDIBELL researchers are involved in projects funded by La Marató de TV3, dedicated to spinal cord and acquired brain injuries. They are María Berdasco, research group of Cancer Epigenetics; Artur Llobet, research group of celular and Molecular Neurobiology; Cristina Muñoz Pinedo, head of the research group of Cell Death regulation; Antoni Rodríguez-Fornells, head of
La Marató de TV3 finance five projects involving IDIBELL researchers Read More »
The IDIBELL and the University Hospital of Bellvitge have received one of the awards to the Best Ideas of the Year, awarded by the newspaper specializing in medicine and health ‘Diario Médico’, for their therapeutic videogame, called Islands, directed to complement the therapy of patients with eating disorders or pathological gambling addiction. This is the
This is the big question that drives all the research in the laboratory of Genetic Systems directed by the ICREA researcher Ben Lehner at the Center for Genomic Regulation in Barcelona. Lehner explained their latest findings on an IDIBELL seminar on November 4th. Lehner’s group seeks to understand why two genetically identical individuals, which have
Ben Lehner: Why would a mutation kill me, but not you?” Read More »
Between November 7 to 20 the Science Week is is celebrated throughout Europe. This is an initiative that aims to bring the results of scientific research to society. More information at Bellvitge Researches
IDIBELL brings science to everyone during the Science Week Read More »
High consumption of alcohol (more than 60 grams per day) significantly increases the risk of gastric cancer. So concludes a study conducted by the Nutrition, Environment and Cancer research Group of the IDIBELL at the Catalan Institute of Oncology that has been published in American Journal of Clinical Nutrition.. The association between alcohol and gastric
High alcohol consumption doubles the risk of gastric cancer Read More »
The researcher at the University of Extremadura Peter M. Salguero Fernandez explained their latest advances in research on the role of transposons, short DNA sequences that move around the genome, on gene regulation. It was on October 28 in the cycle of seminars IDIBELL. Salguero Fernandez stressed the need to study this genetic material, “until
Pedro M. Fernández Salguero: “Transposons could represent up to 15% of the human genome” Read More »
Marcus Buschbeck, researcher at the Institute of Predictive and Personalized Medicine of Cancer (IMPPC) of Badalona has explained its latest advances in the investigation of a protein involved in DNA packaging and its involvement in cell differentiation in the October 21 cycle IDIBELL seminars. The aim of Buschbeck group is to understand how cell changes
Most malignant cells die; only survive those who adapt better Certain healthy liver cells promote an adaptive response in colorectal cancer cells by inhibiting proliferation and causing their death. Tumor cells, that adapt themselves to new conditions, change their behavior and morphology, favoring migration. Researchers from the IDIBELL and the Catalan Institute of Oncology (ICO), coordinated by David Garcia Molleví have published the results of this study in the journal Neoplasia . A hostile microenvironment Article’s reference
